ONKOLOGIA ZELULARRA
![Foto de ONKOLOGIA ZELULARRA](/img/grupo.png)
![Foto de Institute Catalá Oncología](/img/noimage_org.png)
Institute Catalá Oncología
Barcelona, EspañaInstitute Catalá Oncología -ko ikertzaileekin lankidetzan egindako argitalpenak (6)
2022
-
Considerations on diagnosis and surveillance measures of PTEN hamartoma tumor syndrome: clinical and genetic study in a series of Spanish patients
Orphanet Journal of Rare Diseases, Vol. 17, Núm. 1
2020
-
Reply to: Comment to: Helicobacter pylori seroprevalence in Spain: influence of adult and childhood sociodemographic factors
European Journal of Cancer Prevention
2019
-
Helicobacter pylori seroprevalence in Spain: Influence of adult and childhood sociodemographic factors
European Journal of Cancer Prevention, Vol. 28, Núm. 4, pp. 294-303
2017
-
Gemcitabine–erlotinib versus gemcitabine–erlotinib–capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group
European Journal of Cancer, Vol. 75, pp. 73-82
-
Helicobacter pylori antibody reactivities and colorectal cancer risk in a case-control study in Spain
Frontiers in Microbiology, Vol. 8, Núm. MAY
2015
-
Population-based multicase-control study in common tumors in Spain (MCC-Spain): Rationale and study design
Gaceta Sanitaria, Vol. 29, Núm. 4, pp. 308-315